Android app Apple app link

Immunovant's batoclimab shows 'impressive' efficacy in MG, says H.C. Wainwright

By Yahoo! Finance   |   1 month ago
Immunovant's batoclimab shows 'impressive' efficacy in MG, says H.C. Wainwright

Immunovant's drug, IMVT-1402, showed significant improvements in myasthenia gravis and chronic inflammatory demyelinating polyneuropathy. Analysts view the results positively, though efficacy compared to other similar drugs remains a topic of debate.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.